Global Anti-inflammatory Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 261545
  • calendar_today Published On: Jan, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Anti-inflammatory Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Anti-inflammatory Therapeutics market size is estimated to be worth US$ 113740 million in 2021 and is forecast to a readjusted size of USD 169200 million by 2028 with a CAGR of 5.8% during review period. Arthritis accounting for % of the Anti-inflammatory Therapeutics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Anti-inflammatory Biologics segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Anti-inflammatory Therapeutics include AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, and Pfizer, Inc, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Anti-inflammatory Therapeutics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Anti-inflammatory Biologics

Non-Steroidal Anti-inflammatory Drugs (NSAIDs)

Corticosteroids

Others

Market segment by Application, can be divided into

Arthritis

Respiratory Diseases

Dermatology

Gastroenterology

Others

Market segment by players, this report covers

AbbVie

Johnson & Johnson

Amgen Inc

AstraZeneca PLC

Pfizer, Inc

Novartis

Roche

Merck

Sanofi

GlaxoSmithKline

Sun Pharmaceutical Industries Ltd

TEVA

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Anti-inflammatory Therapeutics product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Anti-inflammatory Therapeutics, with revenue, gross margin and global market share of Anti-inflammatory Therapeutics from 2019 to 2022.

Chapter 3, the Anti-inflammatory Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Anti-inflammatory Therapeutics market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Anti-inflammatory Therapeutics research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Anti-inflammatory Therapeutics

1.2 Classification of Anti-inflammatory Therapeutics by Type

1.2.1 Overview: Global Anti-inflammatory Therapeutics Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Type in 2021

1.2.3 Anti-inflammatory Biologics

1.2.4 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)

1.2.5 Corticosteroids

1.2.6 Others

1.3 Global Anti-inflammatory Therapeutics Market by Application

1.3.1 Overview: Global Anti-inflammatory Therapeutics Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Arthritis

1.3.3 Respiratory Diseases

1.3.4 Dermatology

1.3.5 Gastroenterology

1.3.6 Others

1.4 Global Anti-inflammatory Therapeutics Market Size & Forecast

1.5 Global Anti-inflammatory Therapeutics Market Size and Forecast by Region

1.5.1 Global Anti-inflammatory Therapeutics Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Anti-inflammatory Therapeutics Market Size by Region, (2017-2022)

1.5.3 North America Anti-inflammatory Therapeutics Market Size and Prospect (2017-2028)

1.5.4 Europe Anti-inflammatory Therapeutics Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Anti-inflammatory Therapeutics Market Size and Prospect (2017-2028)

1.5.6 South America Anti-inflammatory Therapeutics Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Anti-inflammatory Therapeutics Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Anti-inflammatory Therapeutics Market Drivers

1.6.2 Anti-inflammatory Therapeutics Market Restraints

1.6.3 Anti-inflammatory Therapeutics Trends Analysis

2 Company Profiles

2.1 AbbVie

2.1.1 AbbVie Details

2.1.2 AbbVie Major Business

2.1.3 AbbVie Anti-inflammatory Therapeutics Product and Solutions

2.1.4 AbbVie Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 AbbVie Recent Developments and Future Plans

2.2 Johnson & Johnson

2.2.1 Johnson & Johnson Details

2.2.2 Johnson & Johnson Major Business

2.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Product and Solutions

2.2.4 Johnson & Johnson Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Johnson & Johnson Recent Developments and Future Plans

2.3 Amgen Inc

2.3.1 Amgen Inc Details

2.3.2 Amgen Inc Major Business

2.3.3 Amgen Inc Anti-inflammatory Therapeutics Product and Solutions

2.3.4 Amgen Inc Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Amgen Inc Recent Developments and Future Plans

2.4 AstraZeneca PLC

2.4.1 AstraZeneca PLC Details

2.4.2 AstraZeneca PLC Major Business

2.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Product and Solutions

2.4.4 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 AstraZeneca PLC Recent Developments and Future Plans

2.5 Pfizer, Inc

2.5.1 Pfizer, Inc Details

2.5.2 Pfizer, Inc Major Business

2.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Product and Solutions

2.5.4 Pfizer, Inc Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Pfizer, Inc Recent Developments and Future Plans

2.6 Novartis

2.6.1 Novartis Details

2.6.2 Novartis Major Business

2.6.3 Novartis Anti-inflammatory Therapeutics Product and Solutions

2.6.4 Novartis Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Novartis Recent Developments and Future Plans

2.7 Roche

2.7.1 Roche Details

2.7.2 Roche Major Business

2.7.3 Roche Anti-inflammatory Therapeutics Product and Solutions

2.7.4 Roche Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Roche Recent Developments and Future Plans

2.8 Merck

2.8.1 Merck Details

2.8.2 Merck Major Business

2.8.3 Merck Anti-inflammatory Therapeutics Product and Solutions

2.8.4 Merck Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Merck Recent Developments and Future Plans

2.9 Sanofi

2.9.1 Sanofi Details

2.9.2 Sanofi Major Business

2.9.3 Sanofi Anti-inflammatory Therapeutics Product and Solutions

2.9.4 Sanofi Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Sanofi Recent Developments and Future Plans

2.10 GlaxoSmithKline

2.10.1 GlaxoSmithKline Details

2.10.2 GlaxoSmithKline Major Business

2.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Product and Solutions

2.10.4 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 GlaxoSmithKline Recent Developments and Future Plans

2.11 Sun Pharmaceutical Industries Ltd

2.11.1 Sun Pharmaceutical Industries Ltd Details

2.11.2 Sun Pharmaceutical Industries Ltd Major Business

2.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product and Solutions

2.11.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Sun Pharmaceutical Industries Ltd Recent Developments and Future Plans

2.12 TEVA

2.12.1 TEVA Details

2.12.2 TEVA Major Business

2.12.3 TEVA Anti-inflammatory Therapeutics Product and Solutions

2.12.4 TEVA Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 TEVA Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Anti-inflammatory Therapeutics Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Anti-inflammatory Therapeutics Players Market Share in 2021

3.2.2 Top 10 Anti-inflammatory Therapeutics Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Anti-inflammatory Therapeutics Players Head Office, Products and Services Provided

3.4 Anti-inflammatory Therapeutics Mergers & Acquisitions

3.5 Anti-inflammatory Therapeutics New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Anti-inflammatory Therapeutics Revenue and Market Share by Type (2017-2022)

4.2 Global Anti-inflammatory Therapeutics Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2017-2022)

5.2 Global Anti-inflammatory Therapeutics Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Anti-inflammatory Therapeutics Revenue by Type (2017-2028)

6.2 North America Anti-inflammatory Therapeutics Revenue by Application (2017-2028)

6.3 North America Anti-inflammatory Therapeutics Market Size by Country

6.3.1 North America Anti-inflammatory Therapeutics Revenue by Country (2017-2028)

6.3.2 United States Anti-inflammatory Therapeutics Market Size and Forecast (2017-2028)

6.3.3 Canada Anti-inflammatory Therapeutics Market Size and Forecast (2017-2028)

6.3.4 Mexico Anti-inflammatory Therapeutics Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Anti-inflammatory Therapeutics Revenue by Type (2017-2028)

7.2 Europe Anti-inflammatory Therapeutics Revenue by Application (2017-2028)

7.3 Europe Anti-inflammatory Therapeutics Market Size by Country

7.3.1 Europe Anti-inflammatory Therapeutics Revenue by Country (2017-2028)

7.3.2 Germany Anti-inflammatory Therapeutics Market Size and Forecast (2017-2028)

7.3.3 France Anti-inflammatory Therapeutics Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Anti-inflammatory Therapeutics Market Size and Forecast (2017-2028)

7.3.5 Russia Anti-inflammatory Therapeutics Market Size and Forecast (2017-2028)

7.3.6 Italy Anti-inflammatory Therapeutics Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Anti-inflammatory Therapeutics Revenue by Type (2017-2028)

8.2 Asia-Pacific Anti-inflammatory Therapeutics Revenue by Application (2017-2028)

8.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region

8.3.1 Asia-Pacific Anti-inflammatory Therapeutics Revenue by Region (2017-2028)

8.3.2 China Anti-inflammatory Therapeutics Market Size and Forecast (2017-2028)

8.3.3 Japan Anti-inflammatory Therapeutics Market Size and Forecast (2017-2028)

8.3.4 South Korea Anti-inflammatory Therapeutics Market Size and Forecast (2017-2028)

8.3.5 India Anti-inflammatory Therapeutics Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Anti-inflammatory Therapeutics Market Size and Forecast (2017-2028)

8.3.7 Australia Anti-inflammatory Therapeutics Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Anti-inflammatory Therapeutics Revenue by Type (2017-2028)

9.2 South America Anti-inflammatory Therapeutics Revenue by Application (2017-2028)

9.3 South America Anti-inflammatory Therapeutics Market Size by Country

9.3.1 South America Anti-inflammatory Therapeutics Revenue by Country (2017-2028)

9.3.2 Brazil Anti-inflammatory Therapeutics Market Size and Forecast (2017-2028)

9.3.3 Argentina Anti-inflammatory Therapeutics Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Anti-inflammatory Therapeutics Revenue by Type (2017-2028)

10.2 Middle East & Africa Anti-inflammatory Therapeutics Revenue by Application (2017-2028)

10.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country

10.3.1 Middle East & Africa Anti-inflammatory Therapeutics Revenue by Country (2017-2028)

10.3.2 Turkey Anti-inflammatory Therapeutics Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Anti-inflammatory Therapeutics Market Size and Forecast (2017-2028)

10.3.4 UAE Anti-inflammatory Therapeutics Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Anti-inflammatory Therapeutics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Anti-inflammatory Therapeutics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Anti-inflammatory Therapeutics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Anti-inflammatory Therapeutics Revenue (USD Million) by Region (2017-2022)

Table 5. Global Anti-inflammatory Therapeutics Revenue Market Share by Region (2023-2028)

Table 6. AbbVie Corporate Information, Head Office, and Major Competitors

Table 7. AbbVie Major Business

Table 8. AbbVie Anti-inflammatory Therapeutics Product and Solutions

Table 9. AbbVie Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 11. Johnson & Johnson Major Business

Table 12. Johnson & Johnson Anti-inflammatory Therapeutics Product and Solutions

Table 13. Johnson & Johnson Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Amgen Inc Corporate Information, Head Office, and Major Competitors

Table 15. Amgen Inc Major Business

Table 16. Amgen Inc Anti-inflammatory Therapeutics Product and Solutions

Table 17. Amgen Inc Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. AstraZeneca PLC Corporate Information, Head Office, and Major Competitors

Table 19. AstraZeneca PLC Major Business

Table 20. AstraZeneca PLC Anti-inflammatory Therapeutics Product and Solutions

Table 21. AstraZeneca PLC Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Pfizer, Inc Corporate Information, Head Office, and Major Competitors

Table 23. Pfizer, Inc Major Business

Table 24. Pfizer, Inc Anti-inflammatory Therapeutics Product and Solutions

Table 25. Pfizer, Inc Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Novartis Corporate Information, Head Office, and Major Competitors

Table 27. Novartis Major Business

Table 28. Novartis Anti-inflammatory Therapeutics Product and Solutions

Table 29. Novartis Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Roche Corporate Information, Head Office, and Major Competitors

Table 31. Roche Major Business

Table 32. Roche Anti-inflammatory Therapeutics Product and Solutions

Table 33. Roche Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Merck Corporate Information, Head Office, and Major Competitors

Table 35. Merck Major Business

Table 36. Merck Anti-inflammatory Therapeutics Product and Solutions

Table 37. Merck Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Sanofi Corporate Information, Head Office, and Major Competitors

Table 39. Sanofi Major Business

Table 40. Sanofi Anti-inflammatory Therapeutics Product and Solutions

Table 41. Sanofi Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors

Table 43. GlaxoSmithKline Major Business

Table 44. GlaxoSmithKline Anti-inflammatory Therapeutics Product and Solutions

Table 45. GlaxoSmithKline Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Sun Pharmaceutical Industries Ltd Corporate Information, Head Office, and Major Competitors

Table 47. Sun Pharmaceutical Industries Ltd Major Business

Table 48. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product and Solutions

Table 49. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. TEVA Corporate Information, Head Office, and Major Competitors

Table 51. TEVA Major Business

Table 52. TEVA Anti-inflammatory Therapeutics Product and Solutions

Table 53. TEVA Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Global Anti-inflammatory Therapeutics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 55. Global Anti-inflammatory Therapeutics Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 56. Breakdown of Anti-inflammatory Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 57. Anti-inflammatory Therapeutics Players Head Office, Products and Services Provided

Table 58. Anti-inflammatory Therapeutics Mergers & Acquisitions in the Past Five Years

Table 59. Anti-inflammatory Therapeutics New Entrants and Expansion Plans

Table 60. Global Anti-inflammatory Therapeutics Revenue (USD Million) by Type (2017-2022)

Table 61. Global Anti-inflammatory Therapeutics Revenue Share by Type (2017-2022)

Table 62. Global Anti-inflammatory Therapeutics Revenue Forecast by Type (2023-2028)

Table 63. Global Anti-inflammatory Therapeutics Revenue by Application (2017-2022)

Table 64. Global Anti-inflammatory Therapeutics Revenue Forecast by Application (2023-2028)

Table 65. North America Anti-inflammatory Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 66. North America Anti-inflammatory Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 67. North America Anti-inflammatory Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 68. North America Anti-inflammatory Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 69. North America Anti-inflammatory Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 70. North America Anti-inflammatory Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 71. Europe Anti-inflammatory Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 72. Europe Anti-inflammatory Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 73. Europe Anti-inflammatory Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 74. Europe Anti-inflammatory Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 75. Europe Anti-inflammatory Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 76. Europe Anti-inflammatory Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 77. Asia-Pacific Anti-inflammatory Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 78. Asia-Pacific Anti-inflammatory Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 79. Asia-Pacific Anti-inflammatory Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 80. Asia-Pacific Anti-inflammatory Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 81. Asia-Pacific Anti-inflammatory Therapeutics Revenue by Region (2017-2022) & (USD Million)

Table 82. Asia-Pacific Anti-inflammatory Therapeutics Revenue by Region (2023-2028) & (USD Million)

Table 83. South America Anti-inflammatory Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 84. South America Anti-inflammatory Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 85. South America Anti-inflammatory Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 86. South America Anti-inflammatory Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 87. South America Anti-inflammatory Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 88. South America Anti-inflammatory Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 89. Middle East & Africa Anti-inflammatory Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 90. Middle East & Africa Anti-inflammatory Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 91. Middle East & Africa Anti-inflammatory Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 92. Middle East & Africa Anti-inflammatory Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 93. Middle East & Africa Anti-inflammatory Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 94. Middle East & Africa Anti-inflammatory Therapeutics Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Anti-inflammatory Therapeutics Picture

Figure 2. Global Anti-inflammatory Therapeutics Revenue Market Share by Type in 2021

Figure 3. Anti-inflammatory Biologics

Figure 4. Non-Steroidal Anti-inflammatory Drugs (NSAIDs)

Figure 5. Corticosteroids

Figure 6. Others

Figure 7. Anti-inflammatory Therapeutics Revenue Market Share by Application in 2021

Figure 8. Arthritis Picture

Figure 9. Respiratory Diseases Picture

Figure 10. Dermatology Picture

Figure 11. Gastroenterology Picture

Figure 12. Others Picture

Figure 13. Global Anti-inflammatory Therapeutics Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 14. Global Anti-inflammatory Therapeutics Revenue and Forecast (2017-2028) & (USD Million)

Figure 15. Global Anti-inflammatory Therapeutics Revenue Market Share by Region (2017-2028)

Figure 16. Global Anti-inflammatory Therapeutics Revenue Market Share by Region in 2021

Figure 17. North America Anti-inflammatory Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Europe Anti-inflammatory Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Asia-Pacific Anti-inflammatory Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. South America Anti-inflammatory Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Middle East and Africa Anti-inflammatory Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 22. Anti-inflammatory Therapeutics Market Drivers

Figure 23. Anti-inflammatory Therapeutics Market Restraints

Figure 24. Anti-inflammatory Therapeutics Market Trends

Figure 25. AbbVie Recent Developments and Future Plans

Figure 26. Johnson & Johnson Recent Developments and Future Plans

Figure 27. Amgen Inc Recent Developments and Future Plans

Figure 28. AstraZeneca PLC Recent Developments and Future Plans

Figure 29. Pfizer, Inc Recent Developments and Future Plans

Figure 30. Novartis Recent Developments and Future Plans

Figure 31. Roche Recent Developments and Future Plans

Figure 32. Merck Recent Developments and Future Plans

Figure 33. Sanofi Recent Developments and Future Plans

Figure 34. GlaxoSmithKline Recent Developments and Future Plans

Figure 35. Sun Pharmaceutical Industries Ltd Recent Developments and Future Plans

Figure 36. TEVA Recent Developments and Future Plans

Figure 37. Global Anti-inflammatory Therapeutics Revenue Share by Players in 2021

Figure 38. Anti-inflammatory Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 39. Global Top 3 Players Anti-inflammatory Therapeutics Revenue Market Share in 2021

Figure 40. Global Top 10 Players Anti-inflammatory Therapeutics Revenue Market Share in 2021

Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 42. Global Anti-inflammatory Therapeutics Revenue Share by Type in 2021

Figure 43. Global Anti-inflammatory Therapeutics Market Share Forecast by Type (2023-2028)

Figure 44. Global Anti-inflammatory Therapeutics Revenue Share by Application in 2021

Figure 45. Global Anti-inflammatory Therapeutics Market Share Forecast by Application (2023-2028)

Figure 46. North America Anti-inflammatory Therapeutics Sales Market Share by Type (2017-2028)

Figure 47. North America Anti-inflammatory Therapeutics Sales Market Share by Application (2017-2028)

Figure 48. North America Anti-inflammatory Therapeutics Revenue Market Share by Country (2017-2028)

Figure 49. United States Anti-inflammatory Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Canada Anti-inflammatory Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Mexico Anti-inflammatory Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Europe Anti-inflammatory Therapeutics Sales Market Share by Type (2017-2028)

Figure 53. Europe Anti-inflammatory Therapeutics Sales Market Share by Application (2017-2028)

Figure 54. Europe Anti-inflammatory Therapeutics Revenue Market Share by Country (2017-2028)

Figure 55. Germany Anti-inflammatory Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. France Anti-inflammatory Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. United Kingdom Anti-inflammatory Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Russia Anti-inflammatory Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Italy Anti-inflammatory Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Asia-Pacific Anti-inflammatory Therapeutics Sales Market Share by Type (2017-2028)

Figure 61. Asia-Pacific Anti-inflammatory Therapeutics Sales Market Share by Application (2017-2028)

Figure 62. Asia-Pacific Anti-inflammatory Therapeutics Revenue Market Share by Region (2017-2028)

Figure 63. China Anti-inflammatory Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Japan Anti-inflammatory Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. South Korea Anti-inflammatory Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. India Anti-inflammatory Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Southeast Asia Anti-inflammatory Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Australia Anti-inflammatory Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. South America Anti-inflammatory Therapeutics Sales Market Share by Type (2017-2028)

Figure 70. South America Anti-inflammatory Therapeutics Sales Market Share by Application (2017-2028)

Figure 71. South America Anti-inflammatory Therapeutics Revenue Market Share by Country (2017-2028)

Figure 72. Brazil Anti-inflammatory Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Argentina Anti-inflammatory Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Middle East and Africa Anti-inflammatory Therapeutics Sales Market Share by Type (2017-2028)

Figure 75. Middle East and Africa Anti-inflammatory Therapeutics Sales Market Share by Application (2017-2028)

Figure 76. Middle East and Africa Anti-inflammatory Therapeutics Revenue Market Share by Country (2017-2028)

Figure 77. Turkey Anti-inflammatory Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Saudi Arabia Anti-inflammatory Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. UAE Anti-inflammatory Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. Methodology

Figure 81. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz